PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver disease |
| Phenotype | C0042373|vascular disease |
| Sentences | 17 |
| PubMedID- 26049073 | vascular disease in patients with nonalcoholic fatty liver disease. |
| PubMedID- 25126490 | Non-alcoholic fatty liver disease (nafld) is associated with increased cardiovascular disease (cvd) risk in children. |
| PubMedID- 24713805 | Cardiovascular disease in patients with non-alcoholic fatty liver disease. |
| PubMedID- 22629731 | The combination of vascular disease in patients with liver disease and portal hypertension syndrome accounted for 70%. |
| PubMedID- 24824123 | Objective: to study the relationship between non-alcoholic steatohepatitis (nash) and atherosclerosis in young and middle-aged patients, and to provide clinical evidence that will aid in prevention and prediction of development of atherosclerosis or cardiovascular diseases in patients with non-alcoholic fatty liver disease (nafld). |
| PubMedID- 24611735 | Although used as a marker of chronic liver disease, ggt correlates with cardiovascular diseases and is an independent marker of cardiovascular risk (14) making it a potentially powerful tool in the risk stratification of patients with bbs. |
| PubMedID- 20460913 | The role of non-alcoholic fatty liver disease in cardiovascular disease. |
| PubMedID- 21251186 | Fatty liver disease is associated with underlying cardiovascular disease in hiv-infected persons(*). |
| PubMedID- 24118857 | Background & aims: non-alcoholic fatty liver disease (nafld) is associated with increased cardiovascular disease (cvd) risk. |
| PubMedID- 23534297 | [cardiovascular disease risk factors in patients with non-alcoholic fatty liver disease]. |
| PubMedID- 25644347 | Background: nonalcoholic fatty liver disease is positively associated with obesity and cardiovascular disease risk. |
| PubMedID- 22189171 | Aims: non-alcoholic fatty liver disease (nafld) is associated with cardiovascular disease. |
| PubMedID- 23326306 | Subjects with significant alcohol intake (>20 g/day) type 2 diabetes mellitus (t2dm), cardiovascular disease (cvd), presence of other liver diseases (alcoholic liver disease, viral hepatitis, autoimmune hepatitis, primary biliary cirrhosis, biliary obstruction, drug-induced liver damage etc. |
| PubMedID- 25820150 | Aims/hypothesis: we examined the association of prevalent and incident cardiovascular disease (cvd) with chronic liver disease in a cohort of community-based people with type 2 diabetes, in order to clarify the relationship between these two important conditions. |
| PubMedID- 23895155 | Post-menopause, there is an increase in body weight, visceral adiposity, and risk of developing non-alcoholic fatty liver disease (nafld), which leads to various cardiovascular diseases (cvds). |
| PubMedID- 25634387 | Background: there is increasing recognition of association of nonalcoholic fatty liver disease (nafld) with cardiovascular disease (cvd). |
| PubMedID- 20879883 | Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. |
Page: 1